BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35297321)

  • 1.
    Lala M; Bhattacharjee S; Ghosh C; Sen A; Sarkar I
    J Biomol Struct Dyn; 2023 May; 41(8):3511-3523. PubMed ID: 35297321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural compounds from
    Kar P; Sharma NR; Singh B; Sen A; Roy A
    J Biomol Struct Dyn; 2021 Aug; 39(13):4774-4785. PubMed ID: 32552595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of potential phytochemicals from
    Khan J; Sakib SA; Mahmud S; Khan Z; Islam MN; Sakib MA; Emran TB; Simal-Gandara J
    J Biomol Struct Dyn; 2022; 40(21):10741-10752. PubMed ID: 34278965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anisotine and amarogentin as promising inhibitory candidates against SARS-CoV-2 proteins: a computational investigation.
    Kar P; Kumar V; Vellingiri B; Sen A; Jaishee N; Anandraj A; Malhotra H; Bhattacharyya S; Mukhopadhyay S; Kinoshita M; Govindasamy V; Roy A; Naidoo D; Subramaniam MD
    J Biomol Struct Dyn; 2022 Jul; 40(10):4532-4542. PubMed ID: 33305988
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Maurya AK; Mishra N
    J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular docking and simulation studies of natural compounds of
    Mitra D; Verma D; Mahakur B; Kamboj A; Srivastava R; Gupta S; Pandey A; Arora B; Pant K; Panneerselvam P; Ghosh A; Barik DP; Mohapatra PKD
    J Biomol Struct Dyn; 2022 Aug; 40(12):5665-5686. PubMed ID: 33459176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyanobacterial metabolites as promising drug leads against the M
    Naidoo D; Roy A; Kar P; Mutanda T; Anandraj A
    J Biomol Struct Dyn; 2021 Oct; 39(16):6218-6230. PubMed ID: 32691680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of natural inhibitors against prime targets of SARS-CoV-2 using molecular docking, molecular dynamics simulation and MM-PBSA approaches.
    Sharma A; Vora J; Patel D; Sinha S; Jha PC; Shrivastava N
    J Biomol Struct Dyn; 2022 Apr; 40(7):3296-3311. PubMed ID: 33183178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
    Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
    J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2.
    Yadav R; Imran M; Dhamija P; Chaurasia DK; Handu S
    J Biomol Struct Dyn; 2021 Oct; 39(17):6617-6632. PubMed ID: 32715956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possibility of HIV-1 protease inhibitors-clinical trial drugs as repurposed drugs for SARS-CoV-2 main protease: a molecular docking, molecular dynamics and binding free energy simulation study.
    Ancy I; Sivanandam M; Kumaradhas P
    J Biomol Struct Dyn; 2021 Sep; 39(15):5368-5375. PubMed ID: 32627689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an
    Pandey P; Rane JS; Chatterjee A; Kumar A; Khan R; Prakash A; Ray S
    J Biomol Struct Dyn; 2021 Oct; 39(16):6306-6316. PubMed ID: 32698689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico bioprospecting of antiviral compounds from marine fungi and mushroom for rapid development of nutraceuticals against SARS-CoV-2.
    Srivastav AK; Jaiswal J; Kumar U
    J Biomol Struct Dyn; 2023 Mar; 41(5):1574-1585. PubMed ID: 34971338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HIV-drug and phyto-flavonoid combination against SARS-CoV-2: a molecular docking-simulation base assessment.
    Swain SS; Singh SR; Sahoo A; Hussain T; Pati S
    J Biomol Struct Dyn; 2022 Sep; 40(14):6463-6476. PubMed ID: 33583350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plant derived active compounds as potential anti SARS-CoV-2 agents: an
    Kashyap D; Jakhmola S; Tiwari D; Kumar R; Moorthy NSHN; Elangovan M; BrĂ¡s NF; Jha HC
    J Biomol Struct Dyn; 2022; 40(21):10629-10650. PubMed ID: 34225565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational investigation on
    Murugan NA; Pandian CJ; Jeyakanthan J
    J Biomol Struct Dyn; 2021 Aug; 39(12):4415-4426. PubMed ID: 32543978
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Mohapatra PK; Chopdar KS; Dash GC; Mohanty AK; Raval MK
    J Biomol Struct Dyn; 2023 Feb; 41(2):435-444. PubMed ID: 34821198
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Sharma P; Joshi T; Joshi T; Mathpal S; Maiti P; Nand M; Chandra S; Tamta S
    J Biomol Struct Dyn; 2023 Feb; 41(2):646-658. PubMed ID: 34854365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: an
    Majumder R; Mandal M
    J Biomol Struct Dyn; 2022 Feb; 40(2):696-711. PubMed ID: 32897138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based virtual screening, molecular dynamics and binding affinity calculations of some potential phytocompounds against SARS-CoV-2.
    Naik SR; Bharadwaj P; Dingelstad N; Kalyaanamoorthy S; Mandal SC; Ganesan A; Chattopadhyay D; Palit P
    J Biomol Struct Dyn; 2022 Sep; 40(15):6921-6938. PubMed ID: 33682632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.